Drug eluting cochlear implants

US9162010B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9162010-B2
Application numberUS-201113284287-A
CountryUS
Kind codeB2
Filing dateOct 28, 2011
Priority dateNov 9, 2010
Publication dateOct 20, 2015
Grant dateOct 20, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Drug delivery systems and biocompatible coatings for use with implantable stimulation devices such as cochlear implants have been developed. These drug delivery systems and coatings comprise polyhydroxyalkanoate (PHA) polymers and copolymers. The drug delivery systems may be used to deliver pharmacologically active substances, for example, directly from a cochlear implant to the inner ear. The coatings can impart lubricity to cochlear devices for ease of insertion of the electrodes. In the preferred embodiment, the drug delivery system comprises a polyhydroxyalkanoate polymer, and in the most preferred embodiment, the PHA polymer comprises poly(4-hydroxybutyrate) (P(4HB)) or copolymer thereof. A particularly preferred embodiment is where the silicone sheath of the cochlear implant electrodes has been surface modified, and coated with P(4HB), and the P(4HB) either contains a pharmacologically active substance or has been coated with such a substance.

First claim

Opening claim text (preview).

We claim: 1. An implantable neural stimulation device comprising an outermost layer of a poly-4-hydroxybutyrate (P4HB) polymer-drug layer applied to-a plasma-activated silicone surface, wherein the P4HB-drug layer is smoother than the silicone surface, as measured by environmental Scanning electron microscopy. 2. The device of claim 1 , wherein a poly-4-hydroxybutyrate (P4HB) polymer undercoating is coated onto the silicone surface. 3. The…

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Next steps

Free tools are coming soon. Tell us what you want to track and we'll notify you.

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9162010B2 cover?
Drug delivery systems and biocompatible coatings for use with implantable stimulation devices such as cochlear implants have been developed. These drug delivery systems and coatings comprise polyhydroxyalkanoate (PHA) polymers and copolymers. The drug delivery systems may be used to deliver pharmacologically active substances, for example, directly from a cochlear implant to the inner ear. The …
Who is the assignee on this patent?
Lenarz Thomas, Schmitz Klaus-Peter, Behrend Detlef, and 4 more
What technology area does this patent fall under?
Primary CPC classification A61L27/34. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).